AYRESVY Trademark

Trademark Overview


On Friday, October 15, 2021, a trademark application was filed for AYRESVY with the United States Patent and Trademark Office. The USPTO has given the AYRESVY trademark a serial number of 97076942. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Tuesday, November 21, 2023. This trademark is owned by GlaxoSmithKline Biologicals SA. The AYRESVY trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatolo...
ayresvy

General Information


Serial Number97076942
Word MarkAYRESVY
Filing DateFriday, October 15, 2021
Status713 - CANCELLED - SECTION 18
Status DateTuesday, November 21, 2023
Registration Number6952882
Registration DateTuesday, January 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateTuesday, November 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Tuesday, November 21, 2023CANCELLATION TERMINATED NO. 999999
Tuesday, November 21, 2023CANCELLED SECTION 18-TOTAL
Monday, September 25, 2023CANCELLATION GRANTED NO. 999999
Wednesday, June 21, 2023CANCELLATION INSTITUTED NO. 999999
Tuesday, January 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 17, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 28, 2022ATTORNEY REVIEW COMPLETED
Monday, September 26, 2022ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Monday, September 26, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, August 30, 2022WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Monday, August 29, 2022ASSIGNED TO PETITION STAFF
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Thursday, August 11, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 20, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, July 15, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, July 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022ASSIGNED TO EXAMINER
Thursday, November 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 19, 2021NEW APPLICATION ENTERED